- Home
- VLGEA vs PGEN Comparison
VLGEA vs PGEN Comparison
Compare VLGEA & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLGEA
- PGEN
- Stock Information
- Founded
- VLGEA 1937
- PGEN 1998
- Country
- VLGEA United States
- PGEN United States
- Employees
- VLGEA N/A
- PGEN N/A
- Industry
- VLGEA Food Chains
- PGEN Biotechnology: Pharmaceutical Preparations
- Sector
- VLGEA Consumer Staples
- PGEN Health Care
- Exchange
- VLGEA Nasdaq
- PGEN Nasdaq
- Market Cap
- VLGEA 541.1M
- PGEN 475.2M
- IPO Year
- VLGEA N/A
- PGEN N/A
- Fundamental
- Price
- VLGEA $36.38
- PGEN $1.85
- Analyst Decision
- VLGEA
- PGEN Strong Buy
- Analyst Count
- VLGEA 0
- PGEN 3
- Target Price
- VLGEA N/A
- PGEN $6.00
- AVG Volume (30 Days)
- VLGEA 94.1K
- PGEN 2.2M
- Earning Date
- VLGEA 06-03-2025
- PGEN 08-13-2025
- Dividend Yield
- VLGEA 2.75%
- PGEN N/A
- EPS Growth
- VLGEA 12.55
- PGEN N/A
- EPS
- VLGEA 3.80
- PGEN N/A
- Revenue
- VLGEA $2,299,253,000.00
- PGEN $4,201,000.00
- Revenue This Year
- VLGEA N/A
- PGEN $158.57
- Revenue Next Year
- VLGEA N/A
- PGEN $1,086.91
- P/E Ratio
- VLGEA $9.67
- PGEN N/A
- Revenue Growth
- VLGEA 3.94
- PGEN N/A
- 52 Week Low
- VLGEA $26.11
- PGEN $0.65
- 52 Week High
- VLGEA $40.15
- PGEN $2.17
- Technical
- Relative Strength Index (RSI)
- VLGEA 37.57
- PGEN 68.77
- Support Level
- VLGEA $36.53
- PGEN $1.56
- Resistance Level
- VLGEA $39.65
- PGEN $2.04
- Average True Range (ATR)
- VLGEA 0.93
- PGEN 0.11
- MACD
- VLGEA -0.29
- PGEN 0.04
- Stochastic Oscillator
- VLGEA 0.60
- PGEN 70.00
About VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.